Aberrant Promoter Methylation Profiles and Association With Survival in Patients With Hepatocellular Carcinoma

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s128058
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Aberrant Promoter Methylation Profiles of Tumor Suppressor Genes in Hepatocellular Carcinoma

American Journal of Pathology
Forensic MedicinePathology
2003English

Clinical Significance of Aberrant DEUP1 Promoter Methylation in Hepatocellular Carcinoma

Oncology Letters
Cancer ResearchOncology
2019English

Aberrant GRK6 Promoter Methylation Is Associated With Poor Prognosis in Hypopharyngeal Squamous Cell Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2015English

APC Promoter Methylation and Protein Expression in Hepatocellular Carcinoma

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
2007English

Aberrant Gene Expression Profiles in Hepatocellular Carcinoma Detected by Microdissection

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2013English

Progesterone Receptor Isoform-Specific Promoter Methylation: Association of PRA Promoter Methylation With Worse Outcome in Breast Cancer Patients

Clinical Cancer Research
Cancer ResearchOncology
2011English

EIF4EBP1 Overexpression Is Associated With Poor Survival and Disease Progression in Patients With Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2015English

Detection of Aberrant Promoter Methylation of RNF180, DAPK1 and SFRP2 in Plasma DNA of Patients With Gastric Cancer

Oncology Letters
Cancer ResearchOncology
2014English

Post-Progression Survival and Progression-Free Survival in Patients With Advanced Hepatocellular Carcinoma Treated by Sorafenib

Hepatology Research
HepatologyInfectious Diseases
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy